Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction

Gabriela Fernández1, Guisselle Arias-Bravo2, Jorge A Bevilacqua3

  • 1Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Santiago, Chile.

Insights

Connexins (Cx) form hemichannels (Cx HCs) in dysferlin-deficient mice, exacerbating muscle damage. Targeting Cx HCs offers a potential therapeutic strategy for dysferlinopathies, a genetic muscle disease.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Dysferlinopathy is a genetic muscle disease caused by mutations in the dysferlin gene (DYSF).
  • Dysferlin protein is crucial for cell membrane repair.
  • Previous models showed membrane repair alone doesn't stop muscle damage in dysferlinopathies.

Purpose of the Study:

  • Investigate novel pathogenic mechanisms in dysferlinopathy.
  • Determine the role of connexins (Cx) in dysferlin-deficient mice.
  • Evaluate connexin hemichannels (Cx HCs) as potential therapeutic targets.

Main Methods:

  • Analysis of connexin expression (Cx39, Cx43, Cx45) in dysferlin-deficient (blAJ) mouse myofibers.
  • Assessment of sarcolemma permeability and intracellular Ca2+ signaling.
  • Generation of blAJ mice with reduced Cx43 and Cx45 expression for functional studies.
  • Evaluation of muscle damage markers (lipid accumulation, internal nuclei, cross-sectional area, creatine kinase) and motor performance.

Main Results:

  • Dysferlin-deficient myofibers express Cx39, Cx43, and Cx45, forming functional Cx HCs.
  • Cx HCs increase sarcolemma permeability and intracellular Ca2+ signaling.
  • blAJ mice exhibit muscle atrophy, lipid accumulation, and poor motor performance.
  • Reducing Cx43 and Cx45 expression in blAJ mice ameliorates muscle and systemic damage.

Conclusions:

  • Connexins (Cx43 and Cx45) play a critical role in a novel pathogenic pathway of dysferlinopathies.
  • Cx HCs contribute to muscle damage and functional decline in dysferlinopathy.
  • Cx HCs represent a promising target for pharmacological intervention in dysferlinopathies.